Yan Li, Ph.D.
Responsibilities & Activities
My grant portfolios include: (1) Small Business Innovation Research/Small Business Technology Transfer Research (SBIR/STTR) program supporting development of therapeutic and diagnostic products (e.g., drug, device, and software) in the areas of type 2 diabetes, obesity, adipose tissue, energy balance, cystic fibrosis, neuroendocrinology, and hormone-related bone and mineral metabolism; (2) Pathway to Independence Awards (K99/R00) in the Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM); and (3) DEM Scientific Conferences Grants (R13). I am also responsible for DEM R21 grants administrative management.
Bioengineering, Biotechnology, and Imaging as applied to Diabetes, Metabolic, and Endocrine Diseases
Cutting-edge technologies that elucidate the mechanisms underlying endocrine and metabolic diseases, including diabetes.
Etiology, molecular pathogenesis, pathophysiology, diagnosis, and treatment of cystic fibrosis and its complications.
Committees & Working Groups
- NIH Training Advisory Committee, Member
- NIDDK Minority Affairs Advisory Committee, Member
- NIDDK SBIR/STTR Committee, Member
- NIDDK Obesity Research Working Group, Member
- DEM Clinical Sciences Working Group, Member
Health Specialist, NIDDK, NIH, 2013-2016
CRTA Fellow, NCI, NIH, 2008-2013
Young Investigator, Department of Food Toxicology, School of Veterinary Medicine, Hannover, Germany, 2004-2005
Ph.D., Center for Research in Molecular Endocrinology, University of Oulu, Finland, 2004